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Abstract
Background: The complications in healthcare systems associated with antibiotic-resistant microorganisms have
resulted in an intense search for new effective antimicrobials. Attractive substances from which novel antibiotics may
be developed are the bacteriocins. These naturally occurring peptides are generally considered to be safe and efficient
at eliminating pathogenic bacteria. Among specific keystone pathogens in periodontitis, Porphyromonas gingivalis is
considered to be the most important pathogen in the development and progression of chronic inflammatory disease.
The aim of the present study was to investigate the antimicrobial effects of different Lactobacillus species and
the two-peptide bacteriocin PLNC8 αβ on P. gingivalis.
Results: Growth inhibition of P. gingivalis was obtained by viable Lactobacillus and culture media from L. plantarum
NC8 and 44048, but not L. brevis 30670. The two-peptide bacteriocin from L. plantarum NC8 (PLNC8 αβ) was found to
be efficient against P. gingivalis through binding followed by permeabilization of the membranes, using Surface
plasmon resonance analysis and DNA staining with Sytox Green. Liposomal systems were acquired to verify membrane
permeabilization by PLNC8 αβ. The antimicrobial activity of PLNC8 αβ was found to be rapid (1 min) and visualized by
TEM to cause cellular distortion through detachment of the outer membrane and bacterial lysis.
Conclusion: Soluble or immobilized PLNC8 αβ bacteriocins may be used to prevent P. gingivalis colonization
and subsequent pathogenicity, and thus supplement the host immune system against invading pathogens
associated with periodontitis.
Keywords: Periodontitis, P. gingivalis, Lactobacillus, Bacteriocin, PLNC8
Abbreviations: CF, 5 (6)-carboxyfluorescein; EDC, N-ethyl-N0-(3 diethylaminopropyl) carbodimide; Kgp, Lysine
gingipain; KRG, Krebs-ringer glucose buffer; NHS, N-hydroxysuccinimide; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine; POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine; Rgp, Arginine gingipain;
SPR, Surface plasmon resonance; TEM, Transmission electron microscopy
Background
There is today an intense search for new antimicrobials
with effective activity and with less possibility to induce
antimicrobial resistance [1]. Attractive substances from
which novel antibiotics may be developed are the bacte-
riocins, a group of bacterially produced compounds used
to fight other bacteria [2]. Bacteriocins have a net
positive charge and express amphipathic structures and
kill microbes through interaction with negatively
charged microbial membrane structures, such as Lipo-
polysaccharide and Lipoteichoic Acid. These mecha-
nisms are more difficult to evade by developing
resistance, compared to metabolic enzymes which usu-
ally are targets for conventional antibiotics.
Periodontitis is a common chronic inflammatory dis-
ease caused by an accumulation of different pathogenic
biofilm-forming bacteria in dental pockets, leading to an
exaggerated immune response that destructs periodontal
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ligament and causes alveolar bone loss. P. gingivalis is
considered a keystone pathogen among these pathogenic
bacteria and is well associated with the development of
periodontitis. P. gingivalis is an anaerobic gram-negative,
black-pigmented bacterium that has been widely associ-
ated as a putative organism in causing aggressive peri-
odontitis and progression into systemic diseases [3]. The
ability of P. gingivalis to invade host cells, including gin-
gival epithelial cells [4] and heart and aortic endothelial
cells [5] demonstrate a possible mechanism for its estab-
lishment and subsequent pathogenesis by evading the
host immune system. P. gingivalis express multiple viru-
lence factors (fimbriae, capsule, LPS, proteinases and
toxic end-products) that contribute significantly to their
pathogenicity by altering host immune responses [6].
However, P. gingivalis virulence is primarily associated
with the elevated proteolytic activity of cysteine protein-
ases (reviewed in [7]) that are divided into arginine-
specific (Rgp) and lysine-specific (Kgp) [8]. Besides the
immunomodulatory effects of P. gingivalis, the bacter-
ium is also able to form biofilms containing extracellular
polymeric substances that provides antibiotic resistance
and a niche for long-term survival within the host by
evading host immune responses. These biofilms are diffi-
cult to treat and conventional methods are still being
used to treat patient with periodontitis, including mech-
anical removal of hard and soft subgingival biofilms,
scaling and chemical treatment to control plaque (metal-
lic salts, antibiotics and phenols). These methods are less
efficient since within a few hours new biofilms are
formed that are prone to cause infections [9]. Fur-
thermore, periodontitis has been associated with other
systemic conditions, such as atherosclerosis, following
identification of periodontal pathogens, including P.
gingivalis, in atherosclerotic plaques [3, 10]. We have
recently shown that P. gingivalis induces gene expres-
sion of angiopoietin 2 in aortic smooth muscle cells,
which increases the migration of the cells that is as-
sociated with the pathogenesis of atherosclerosis [11].
The oral cavity harbours a wide variety of bacteria
from the genus Lactobacillus that play an important role
in the maintenance of a healthy balance of the oral eco-
system and are suggested to have protective effects in
the pathogenesis of periodontal disease [12, 13]. However,
many Lactobacillus species are outcompeted by gram-
negative pathogens, including P. gingivalis, during disease
progression. It has previously been reported that certain
Lactobacillus species, including L. rhamnosus and L. sali-
varius, possess antimicrobial activity against periodontal
pathogens, such as P. gingivalis [14]. Pangsomboon
and colleagues [15] reported that bacteriocins from L.
paracasei were able to kill P. gingivalis at a minimal
concentration of 0.14 mM. Bacteriocins are divided
into three classes depending on their characteristics.
Class I (lantibiotics) are small peptides (<5 kDa) that
contain unusual amino acids, lanthionine and three-
methyllanthionine, introduced by post-translational
modifications. Class II bacteriocins are synthesized in
precursor forms that are processed after two glycine
residues and display structural stability against prote-
olysis, heat and a wide range of pH. This group also
includes bacteriocins composed of two different peptides
that dimerize to form an active poration complex. Class
III includes bacteriocins with large molecules that are
sensitive to heat. Bacteriocins are antimicrobial com-
pounds secreted by bacteria as part of their defence
mechanism. Likewise, L. plantarum NC8 has previ-
ously been shown to produce a two-peptide bacteri-
ocin, composed of PLNC8 α and β, which is classified as
a class II bacteriocin. PLNC8 αβ are heat-stable and re-
ported to possess antimicrobial activity towards gram-
positive bacteria [16].
It is important to determine the anti-bacterial activity
of Lactobacillus species and their bacteriocins, as an al-
ternative method to antibiotic therapy, in preventing
the colonization of P. gingivalis. We hypothesize that
specific Lactobacillus species are able to suppress P.
gingivalis growth, which is primarily due to expression
and secretion of bacteriocins, and that these substances
may be successful in the prevention of periodontitis.
The aim of the present study was to elucidate the proper-
ties and antimicrobial effects of different Lactobacillus




P. gingivalis wild type strains ATCC 33277 (ATCC,
Manassas, VA) and W50, and the W50-derived Kgp
proteinase and Rgp proteinase mutant strains (K1A
and E8, respectively) were a kind gift from Dr. M.A.
Curtis (Molecular Pathogenesis Group, Queen Mary,
University of London). P. gingivalis strains were
grown in anaerobic conditions (80 % N2, 10 % CO2,
and 10 % H2) at 37 °C in an anaerobic chamber
(Concept 400 Anaerobic Workstation; Ruskinn Technol-
ogy Ltd., Leeds, United Kingdom). The bacterial concen-
tration was adjusted to correlate with approximately
109 CFU/ml, which was determined by viable count by
culturing the bacteria on fastidious anaerobe agar
(45.7 g/l, pH 7.2, Acumedia, Neogen, Lansing, USA), sup-
plemented with 5 % defibrinated horse blood for 5 days.
The Lactobacillus strains L. plantarum NC8, L. plan-
tarum 44048 and L. brevis 30670 (Culture Collection,
University of Gothenburg, Sweden) were grown on
deMan Rogosa Sharp (MRS, BD Science) supplemented
with agar (Difco) at 37 °C for 24 h in a jar containing an
oxygen-free environment (Anaerobic pouch system EZ,
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BD Biosciences, CA, USA). Fresh cultures were used to
inoculate MRS broth (Difco, BD Biosciences, CA, USA),
and grown statically and anaerobically for 24 h at 37 °C.
Lactobacillus were grown from a 0.5 % inoculum for
24 h at 37 °C under anaerobic and static growth condi-
tions, and were then used for further experiments. The
two-peptide bacteriocin from L. plantarum NC8, PLNC8
α and β, were purchased from GL Biochem (Shanghai)






Liposomes were prepared according to methods that
are well established in the field [17, 18]. Briefly, lipo-
somes were prepared by dry film formation, hydration
and finally extrusion through a polycarbonate mem-
brane to form monodisperse large unilamellar vesicles.
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
L-serine (POPS) and 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine (POPC) (Avanti Polar Lipids,
Alabaster, USA) were mixed at molar ratios 1:99, 5:95
and 10:90 while dissolved in chloroform. A dry lipid
film was formed by evaporation of the chloroform by
nitrogen flow and overnight lyophilization. The film
was hydrated with either 10 mM phosphate buffer
(PB) pH 7 or 10 mM phosphate buffer saline (PBS)
pH 7, and the solution was vortexed for 1 min and put on
a shaker for 1 h before extruded 21 times through a
100 nm pore-sized polycarbonate membrane. For fluores-
cence leakage assay the lipid film was hydrated with buffer
(PBS) containing self-quenching concentration (50 mM)
of 5 (6)-carboxyfluorescein (CF) (Sigma Aldrich) and
liposomes were prepared as described above. Removal
of unencapsulated CF was done by gel filtration using
a PD-25 column (GE Healthcare, Uppsala, Sweden)
and liposomes with encapsulated CF were eluted with PBS.
Dynamic light scattering and Zeta potential
In order to mimic P. gingivalis membrane compos-
ition and potential, the hydrodynamic radius and zeta
potential was measured on liposomes suspended in
10 mM PB pH 7 and suspensions containing microvesicles
from P. gingivalis W50, using a Malvern ZetaSizer Nano S
(Malvern Instruments Ltd, UK) and a disposable cuvette.
Carboxyfluorescein (CF) release assay
Leakage of the liposome encapsulated fluorophore CF
due to additions of the bacteriocins was recorded using
a fluorescence plate reader (Infinite 200, Tecan, Austria)
where λex = 485 nm and λem = 520 nm. CF was
encapsulated at self-quenching concentration, and CF
release results in an increased fluorescence signal. Lipo-
somes were diluted to 25 μM (total lipid concentration)
in PBS, followed by additions of 0, 0.005, 0.01, 0.02, 0.05,
0.1, 0.2, 0.5, 1 and 2 μM of the peptides PLNC8 α and β,
separately and combined. In order to estimate the max-
imum release from each sample, a final addition of 0.5 %
Triton X-100 was made at the end of all measurements
and the total amount of CF (100 % release) was esti-
mated after 15 min incubation. The CF release is pre-
sented as percentage release for each time interval
(measurements taken every minute). The percentage CF
release is calculated as 100 × (F – F0)/(FT – F0) where F0
is the initial fluorescence intensity of CF before peptide
addition, F is the fluorescence intensity of CF at time
point t and FT is the maximum fluorescence after the
addition of Triton X-100.
Circular Dichroism (CD) spectroscopy
Bacteriocins are often unstructured in solution but typic-
ally adopt a well-defined secondary structure when bound
to the bacterial cell membrane as a result of membrane
partitioning [19]. The secondary structure of the bacterio-
cins was investigated using CD spectroscopy. CD spectra
were recorded using a Chirascan spectropolarimeter
(Applied Photophysics, UK) and a 1 mm quartz cuvette at
20 °C with a sampling interval of 0.5 nm. All measure-
ments were done in triplicates and averaged before
converted to mean residue ellipticity (MRE) and curves
smoothened using Savitzky-Golay algorithm.
Antimicrobial activity of Lactobacillus
The ability of different Lactobacillus strains to inhibit
P. gingivalis growth was assessed on fastidious anaerobe
agar plates. Briefly, different P. gingivalis strains (108 CFU
in 100 μl) were spread onto fastidious anaerobe agar plates
and allowed to dry. Lactobacillus were diluted in MRS
broth and 10 μl drops (106 CFU) were placed onto the P.
gingivalis layer. The plates were incubated for 4 days, after
which images were acquired with Olympus SZX9 at 10×
magnification and the zone of inhibition was measured
using the software ImageJ.
Antimicrobial activity was also assessed using Lactoba-
cillus culture media (MRS broth), in which different
Lactobacillus strains were cultured for 24 h. The bac-
teria were removed by centrifugation at 7000 × g and the
supernatants were sterile filtered (0.2 μm). The pH was
measured and the supernatants were used to determine
antimicrobial activity against P. gingivalis on fastidious
anaerobe agar plates (10 μl drops), as mentioned above.
Antimicrobial activity of bacteriocin PLNC8 αβ
The antimicrobial activity of PLNC8 αβ on P. gingivalis
was visualized using the fluorescent dye Sytox® Green,
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which can only cross damaged membranes and fluoresce
upon binding to nucleic acids. P. gingivalis were washed
and resuspended in Krebs-Ringer Glucose buffer (KRG)
(120 mM NaCl, 4.9 mM KCl, 1.2 mM MgSO4, 1.7 mM
KH2PO4, 8.3 mM Na2HPO4, and 10 mM glucose, pH 7.3)
and incubated in the presence or absence of PLNC8
αβ in 96-well microtiter plates. Images were captured
with Olympus BX41 at 40× magnification.
Transmission electron microscopy (TEM) was used to
visualize the damage of P. gingivalis, caused by PLNC8
αβ. Briefly, P. gingivalis ATCC 33277 were pelleted and
washed with KRG. The bacteria were then treated with
280 nM of PLNC8 αβ in a molar ratio of 1:2 for 2 min
and 10 min, followed by fixation in 2.5 % glutaraldehyde
in 0.1 M phosphate buffer, pH 7.3. Specimens were
washed in 0.1 M phosphate buffer, postfixed in 2 % os-
mium tetroxide in 0.1 M phosphate buffer for 2 h and
embedded into LX-112 (Ladd, Burlington, Vermont,
USA). Ultrathin sections (approximately 50-60 nm) were
cut by a Leica ultracut UCT/ Leica EM UC 6 (Leica,
Wien, Austria). Sections were contrasted with uranyl
acetate followed by lead citrate and examined in a Hitachi
HT 7700 (Tokyo, Japan). Digital images were taken by
using a Veleta camera (Olympus Soft Imaging Solutions,
GmbH, Münster, Germany).
SPR analysis
Surface plasmon resonance analysis was performed by
immobilizing PLNC8 αβ peptides in 1:2 molar ratio onto
a carboxymethylated dextran (CM-5 sensor chip, GE-
Healthcare GmbH, Uppsala, Sweden) using biacore 2000
instrument equipped with four flow cells (GE-Healthcare
GmbH, Uppsala, Sweden). Each channel of the chip was
immobilized with 3 different concentrations of PLNC8
αβ (2.8, 28, 280 nM) respectively, and the fourth channel
was used as a blank for negative reference subtraction
between the channels. HBS-EP (0.01 M HEPES, pH7.4,
0.15 M NaCl, 3 mM EDTA, 0.005 % surfactant P20)
(GE-Healthcare GmbH) was used as running buffer and
the flow cell temperature was set to 25 °C in all experi-
ments. Immobilization was a 3-step process performed
using amine coupling kit (GE-Healthcare GmbH, Uppsala,
Sweden) where the chip surface was activated using
200 mM N-ethyl-N0-(3 diethylaminopropyl) carbodimide
(EDC) and 50 mM N-hydroxysuccinimide (NHS)
mixture. PLNC8 αβ peptides diluted in acetate 4.5
buffer (GE-Healthcare GmbH, Uppsala, Sweden) were
immobilized to the activated surface. Ethanolamine-
HCl (pH 8.5) was used to deactivate the surface to
enable an efficient binding of samples to the immobilized
ligand. The contact time was 7 min, which resulted in
immobilization levels between 1350 and 1750 response
units (RU). One thousand RU corresponds to a surface
peptide concentration of about 1 ng/mm2.
P. gingivalis were washed and prepared as described
above after which the bacteria were pre-incubated with
2.8, 28 or 280 nM of PLNC8 αβ for 5 min at room
temperature before analysis. P. gingivalis without PLNC8
αβ was used as positive control. The binding affinity of
the bacteria to the peptides immobilized on each
channel of the chip was measured in response units
(RU). 1RU = 1 pg/mm2 using Bia-evaluation software [20].
Immobilization of surfaces with P. gingivalis-specific
antibodies produced and tested as described in our previ-
ous studies [21], were used to study the binding affinity of
P. gingivalis with and without PLNC8 αβ to the immobi-
lized antibodies. Samples were prepared as described
above and the responses obtained from Bia-evaluation
software were plotted. The immobilization response for
anti-P. gingivalis antibodies was 6400 RU.
Statistical analysis
All data were analyzed using GraphPad Prism 5.0
(GraphPad Software, La Jolla, CA, USA). One-way ANOVA
with Tukey’s multiple comparison test was used for the
comparisons between the different treatments. P-values are
referred to as *,#p < 0.05; **,##p < 0.01; ***,###p < 0.001.
Results
Lactobacillus spp. suppress P. gingivalis growth
Antimicrobial activity of different Lactobacillus strains
(L. brevis 30670, L. plantarum 44048 and L. plantarum
NC8) was assessed by co-culture with different P. gingi-
valis strains. L. brevis 30670 did not affect the growth of
any of the P. gingivalis strains, while L. plantarum 44048
and NC8 could significantly inhibit all P. gingivalis strains
(Fig. 1). Interestingly, P. gingivalis that lack Kgp proteinase
activity was more susceptible to growth inhibition than
the wild-type (WT) and the Rgp-deficient strain E8.
Since Lactobacillus are able to lower the pH in their
environment, we have investigated if the antimicrobial
activity of lactic acid bacteria was due to acidic pH. The
growth media from all three Lactobacillus strains were
found to be acidic (pH 3.4-4.1). However, antimicrobial
activity against P. gingivalis was only found in media de-
rived from L. plantarum 44048 and L. plantarum NC8
(data not shown). This prompted us to determine if these
effects are due to bacteriocins, since acidic pH was not a
contributing factor for the observed antimicrobial activity.
PLNC8 α and β are two peptides produced by L. plan-
tarum NC8 that form an active poration complex with
antimicrobial activity. Thus, the effect of PLNC8 αβ on
P. gingivalis viability was investigated by utilizing the
fluorescent dye Sytox Green, which can only cross dam-
aged membranes and fluoresce upon binding to nucleic
acids. The uptake of Sytox Green by wild type P. gingi-
valis ATCC 33277 (Fig. 2a) and W50 (Fig. 2b) was
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significantly enhanced with increasing concentrations of
PLNC8 αβ, which indicates a disordered integrity of P.
gingivalis membranes. Interestingly, the effect of PLNC8
αβ bacteriocins was observed to be instant, as fluores-
cence was detected immediately after addition of PLNC8
αβ, reaching maximum intensity already after 1 min.
Influence of PLNC8 αβ on model lipid membrane integrity
A carboxyfluorescein (CF) release assay was used in
order to investigate the effect of the bacteriocins on the
integrity of model lipid membranes. Extrusion of lipo-
somes resulted in large unilamellar vesicles (LUVs) with
a hydrodynamic diameter of about 123 nm and a zeta
Fig. 2 Bacteriocin PLNC8 αβ from L. plantarum NC8 is efficient against P. gingivalis. The antimicrobial activity of PLNC8 αβ on wild type (WT) P.
gingivalis ATCC 33277 (a) and W50 (b), respectively, was visualized using the fluorescent dye Sytox® Green. Images were acquired using Olympus
BX41 at 40× magnification. The antimicrobial effect of PLNC8 αβ was rapid and a significant number of P. gingivalis cells could fluoresce already
after 1 min, indicating damaged membranes. Representative images and quantitative data of at least three independent experiments are shown.
Quantitative data were normalized and the controls at each time point were set to 1. ***p < 0.001, *- significance from the control at each time
point. Scale bar = 300 μm
Fig. 1 Lactobacillus suppresses P. gingivalis growth. Images were acquired after coculture of P. gingivalis with Lactobacillus for 4 days, using
Olympus SZX9 at 10× magnification. The zone of inhibition was measured using ImageJ, n = 3. White lines indicate the inhibition zone.
Prevention of P. gingivalis growth by Lactobacillus was shown to be species dependent. */#p < 0.05; **/##p < 0.01; ***/###p < 0.001, *- significance from
L. brevis 30670 within each P. gingivalis strain, #- significance from WT W50 between the same Lactobacillus strain
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potential of -24 mV. The lipid composition (5:95 POPS:
POPC) was chosen to mimic the zeta potential of micro-
vesicles present in the supernatant retrieved cultures of
P. gingivalis W50 (-24.8 mV) (Fig. 3).
The CF release was monitored over time using con-
centrations of bacteriocins ranging from 0.005 to 2 μM.
The relative release after 30 min incubation with PLNC8
α, PLNC8 β and PLNC8 αβ (molar ratio 1:2) is shown in
Fig. 4a. While CF release without addition of bacterio-
cins were < 1 %, a 30 min incubation with 2 μM PLNC8
α caused about 70 % release of CF and the same concen-
tration of PLNC8 β induced almost complete release of
the liposomal content (97.5 %). It is noteworthy that
even for low concentrations of PLNC8 β the release of
CF was high. As little as 0.05 μM (~0.002 peptide/lipid)
PLNC8 β caused about 80 % CF release in 30 min. For
PLNC8 αβ, the release kinetics and extent of release was
similar to PLNC8 β alone for concentrations < 0.2 μM,
whereas higher concentrations resulted in slightly higher
release for PLNC8 αβ. The CF release assay thus indi-
cates that both peptides bind to lipid membranes result-
ing in a significant reduction in membrane integrity.
Interestingly, in model membranes the effect of PLNC8
β was comparable to the effect of PLNC8 αβ and the
contribution from PLNC8 α thus appeared to be almost
negligible. PLNC8 α alone did however cause significant
leakage of CF albeit at a higher concentration than
PLNC8 αβ. The release kinetics for PLNC8 α and β
(Fig. 4b and c respectively) show that membrane disruption
was almost immediate after exposure to the bacteriocins.
Within the first couple of minutes, the CF release had
already saturated. The maximum release increased with in-
creasing concentration of bacteriocin. At lower concentra-
tions a large fractions of liposomes were unaffected.
Bacteriocin secondary structure
By using CD spectroscopy we found that PLNC8 α showed
no signs of ordered secondary structure (i.e. random coil)
in the absence of lipid membranes (Fig. 5). PLNC8 β, on
the other hand, showed CD spectra indicative of α-helical
secondary structure. In the presence of POPS:POPC (5:95)
LUVs, both peptides underwent a structural transition,
which was quite prominent for PLNC8 β that adopted a
distinct β -sheet conformation. PLNC8 α demonstrated a
shift in the CD spectrum indicating a certain amount of α-
helical structure.
The bacteriocin PLNC8 αβ binds to P. gingivalis
The antimicrobial activity of bacteriocins is dependent
on binding to common epitopes on bacterial surfaces.
Although binding of bacteriocins alone does not attri-
bute for damage of bacterial membranes, we show that
the antimicrobial effect of PLNC8 αβ on P. gingivalis is
evident (Fig. 2). It is therefore important to determine if
these effects are specific through binding of PLNC8 αβ
to P. gingivalis. Both P. gingivalis ATCC 33277 (Fig. 6a)
and W50 (Fig. 6b) were shown to bind to immobilized
bacteriocin PLNC8 αβ (280 nM). Furthermore, pre-
incubation of P. gingivalis with increasing concentra-
tions of PLNC8 αβ caused a dose-dependent decrease in
binding of the bacteria to the immobilized PLNC8 αβ
peptides. Interestingly, pre-incubation of the bacteria
with low concentrations of PLNC8 αβ (2.8 nM) were
able to significantly decrease the binding, compared to
untreated bacteria, indicating high specificity and bind-
ing affinity. Similar results were obtained with channels
immobilized with 2.8, 28 and 2800 nM of PLNC8 αβ
and with similar pre-treatments (data not shown).
The binding of PLNC8 αβ to P. gingivalis was verified
using channels immobilized with anti-P. gingivalis anti-
bodies. Both ATCC 33277 (Fig. 6c) and W50 (Fig. 6d)
bound to the immobilized antibodies. This binding was
significantly reduced in a dose-dependent manner fol-
lowing pre-incubation of the bacteria with increasing
concentrations of PLNC8 αβ. The results suggest that
the damage caused by PLNC8 αβ bacteriocins alters the
integrity of P. gingivalis membranes, resulting in modi-
fied epitopes with reduced binding to the antibodies,
compared to untreated bacteria.
Rapid rupture of the outer membrane
The binding and antimicrobial effect of PLNC8 αβ on P.
gingivalis is evident, which prompted us to visualize the
nature of the damage caused by these peptides. P. gingi-
valis ATCC 33277 were either left untreated or treated
with 280 nM of PLNC8 αβ for 2 and 10 min, followed
by morphological studies using TEM. Untreated P. gingi-
valis cells showed typical coccobacillus morphology in
which the outer and inner membrane are apparent and
can be distinguished (Fig. 7). Interestingly, treatment of
the bacteria with PLNC8 αβ for 2 min resulted in leak-
age of intracellular content, which may be due to pore
Fig. 3 Zeta potential and size of liposomes and W50 microvesicles.
The zeta potential and size of liposomes with different lipid composition
was measured to identify the best match with microvesicles
from P. gingivalis W50. All measurements are done in triplicates
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formation. Furthermore, bacteriocin treatment caused
detachment of the outer membrane. After 10 min of
treatment, a large number of distorted and completely
separated membranes were observed. These findings
confirm that the effects of PLNC8 αβ on P. gingivalis
are specific and instant.
Discussion
The overuse of antibiotics have increased the occurrence
of complications in healthcare systems due to bacterial
resistance, which in turn have resulted in an intense
search for new and effective antimicrobials with less pos-
sibility to induce antimicrobial resistance. This study
suggests that Lactobacillus and bacteriocin PLNC8 αβ
can be used as an alternative method to antibiotic
therapy in the prevention and treatment of infectious
diseases, including periodontitis.
Lactobacillus species are part of the normal flora of
humans, and have been reported to be important con-
tributors to the balance of oral microflora by preventing
pathogen colonization and thus maintaining a healthy
state [22]. However, the mechanisms by which Lactoba-
cillus interacts with periodontal pathogens and promotes
health benefits are sparsely investigated. The oral cavity
harbors a wide variety of Lactobacillus species, including
L. gasseri, L. salivarius, L. brevis, L. plantarum and L.
rhamnosus [22, 23]. Although the majority of these spe-
cies are frequently found in the mouth, we show that
Fig. 4 Dose- and time dependent release of CF in response to bacteriocin PLNC8 αβ. a Release of 5 (6)-carboxyfluorescein (CF) from liposomes
(5:95 POPS: POPC) after 30 min with addition of PLNC8 α (red), β (blue) and αβ 1:2 (green). The interaction kinetics was recorded every minute for
PLNC8 α (b) and PLNC8 β (c) with the liposomes and is displayed in increasing bacteriocin concentration (0.005–2 μM) indicated by the arrow.
The total lipid concentration was kept constant at 25 μM. CF release without addition of bacteriocins were < 1 % and all data points are average
of n = 3. The thick red and blue lines in B and C indicate the highest peptide concentration
Fig. 5 Secondary structure change of PLNC8 α and β. CD spectra of 100 μM PLNC8 α (a) and PLNC8 β (b) in solution (dashed lines) and with
1 mM (total lipid concentration) 5:95 POPS:POPC liposomes (solid lines) in 10 mM PB pH 7, 20 °C
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they possess different specificity towards inhibition of P.
gingivalis. While L. brevis 30670 was ineffective at inhi-
biting growth of the four P. gingivalis strains investigated
in this study, both L. plantarum NC8 and 44048 were
able to significantly suppress P. gingivalis growth. Fur-
thermore, although inhibition zones correlate with the
ability of an antimicrobial agent to diffuse through a
semi-solid matrix, the Kgp-deficient P. gingivalis strain
K1A was more susceptible to growth inhibition com-
pared to its parent wild type strain W50 and Rgp-
deficient strain E8, indicating an essential role for Kgp in
P. gingivalis survival. The inhibition may possibly be due
Fig. 6 PLNC8 αβ binds to P. gingivalis in a dose-dependent manner. Binding of P. gingivalis to PLNC8 αβ and to anti- P.gingivalis antibodies was
analyzed by SPR. Both P. gingivalis ATCC 33277 (a) and W50 (b) were found to bind to immobilized PLNC8 αβ (280 nM). The binding was verified
by pre-incubating the bacteria with different concentrations of soluble PLNC8 αβ prior to analysis, which resulted in a significantly reduced binding to
the immobilized bacteriocins. Pre-incubation of P. gingivalis ATCC 33277 (c) and W50 (d) with increasing concentrations of soluble PLNC8 αβ prior to
analysis reduced the bacterial binding to anti-P. gingivalis antibodies in a dose-dependent manner. Results are presented from three independent
experiments. *p < 0.05; **p < 0.01; ***p < 0.001
Fig. 7 The bacteriocin PLNC8 αβ damages the membrane of P. gingivalis. Bacterial ultrastructure was examined using a Hitachi HT 7700 transmission
electron microscope and showed typical coccobacillus shapes of untreated P. gingivalis, where the outer membrane (OM) and cytoplasmic
membrane (CM) could be clearly distinguished. Treatment with PLNC8 αβ (1:2) efficiently damaged ccells by causing rupture of the bacterial
membrane and leakage of intracellular content (red arrow head), eventually resulting in completely detached outer membrane (black arrow
heads). Scale bar = 200 nm
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to secretion of active antimicrobial peptides, as the cell-
free conditioning media from L. plantarum NC8 and
44048, but not L. brevis 30670, caused obvious inhib-
ition, independent of the low pH.
L. plantarum NC8 has previously been reported to ex-
press a two-peptide bacteriocin, composed of PLNC8 α
and β, in the presence of other bacteria [24, 25]. We
show that these peptides are effective against P. gingivalis
by damaging the membrane integrity and allowing the
fluorescent dye Sytox Green to enter. By considering the
amino acid sequences of PLNC8 αβ (Additional file 1:
Figure S1), it is evident that lysine residues (PLNC8
α-4; PLNC8 β-5) are more abundant than arginine
residues (PLNC8 α-1; PLNC8 β-1). It is therefore reason-
able to suggest a role for the proteinase Kgp in cleaving
PLNC8 α and β. This is supported by the fact that P.
gingivalis lacking Kgp was more susceptible to growth
inhibition by L. plantarum NC8, compared to WT W50.
The proteinases Kgp and RgpA/B account for >80 % of
the proteolytic activity of P. gingivalis [26]. Studies have
established the potent enzymatic activity of cysteine pro-
teinases through degradation of cytokines [27], epithelial
junctional proteins [28] and immune receptors [29, 30].
We have recently shown that Kgp, but not Rgps, was asso-
ciated with suppression of CXCL8 and IL-6 accumulation,
induction of TGF-β1 and fibroblast cell viability [31]. The
possible degradation of PLNC8 α and β by P. gingivalis-
derived proteinases is currently under investigation.
Although bacteriocins are generally considered to tar-
get bacteria that are closely related to the bacteriocin-
producing species, our results suggest that PLNC8 αβ
may be used to suppress P. gingivalis growth and pre-
vent its establishment. The reported narrow-spectrum
activity of most bacteriocins [2] could suggest that their
mechanism of action is primarily mediated through
binding to specific receptors. Diep and colleagues [32]
showed that the class II bacteriocin lactococcin A from
Lactococcus lactis, binds to the membrane-located com-
ponents IIC and IID of the mannose phosphotransferase
system on target bacteria. Although P. gingivalis con-
tains functional glucose/galactose transporters, these
processes have mainly been associated with the LPS syn-
thesis pathway [33]. Genetic analysis of P. gingivalis sug-
gest that amino acids are the primary source for growth,
while the uptake/metabolism of carbohydrates is limited
[34]. Furthermore, plantaricin EF (two-peptide bacteri-
ocin, subclass IIb) from L. plantarum C11 did not ex-
ploit the mannose phosphotransferase system to kill
susceptible bacteria [32], suggesting that the two-peptide
bacteriocins have a different mechanism of action. The
calculated net charge for PLNC8 α and β at pH 7 is 4.1
and 5.2, respectively. These positively charged peptides
may be attracted to the negatively charged components
lipid A and phosphate groups of the LPS molecule,
which initiates the initial interaction prior to pore for-
mation. By incorporating LPS or lipid A into liposomes,
to resemble the outer membrane of gram-negative bac-
teria, Matsuzaki et al. [35] were able to show that the
antimicrobial peptide magainin was attracted to the
negatively charged lipid A and formed a helix upon
binding. This appears to be a common mechanism applied
by a range of different naturally occurring and synthetic
cationic antimicrobial peptides [36–38], and could thus be
used to reduce LPS-induced inflammation and sepsis.
Scott and colleagues [39] showed that neutralization of
the inflammatory effects of LPS by human α-defensin-1,
human β-defensin-2 and other synthetic peptides, was due
to prevention of LPS interaction with the acute-phase
LPS-binding protein.
Our studies with model membranes suggest that the
bacteriocins may interact with lipid membranes without
a specific target epitope. The interaction is most likely
due to an initial electrostatic attraction between the cat-
ionic bacteriocins (Additional file 1: Figure S1) and the
anionic lipid membrane, which is commonly seen in the
mechanisms of many antimicrobial peptides [40]. It has
previously been shown that P. gingivalis cells are highly
negatively charged at pH > 3 [41]. An increased concen-
tration of bacteriocins on the liposome surface will in
turn cause an increase in permeability of the liposomes.
This increased permeability is related to the structural
changes that were observed when the bacteriocins inter-
act with the liposome surface, likely due to partition-
folding coupling due to their amphipathic properties
(Additional file 1: Figure S1) [40]. The studies on the
model membrane showed that both bacteriocins indi-
vidually cause disruption of the membrane integrity, al-
though the effect was more pronounced for PLNC8 β.
Efforts have been made to screen for and synthesize
antimicrobial peptides against P. gingivalis, considering
its role as a keystone pathogen in periodontitis. In a
study where 236 lactic acid bacterial isolates from food
were included, none of the tested strains was able to
affect the growth of gram-negative periodontal patho-
gens, including P. gingivalis [42]. Antimicrobial agents
from L. paracasei HL32 have been shown to suppress P.
gingivalis growth [43, 44], and a short biosynthetic pep-
tide, Pep-7, was produced and demonstrated to be se-
lectively active against P. gingivalis [45]. We show that
the antimicrobial effect of the two-peptide bacteriocin
PLNC8 αβ occur rapidly and is very efficient, using lipo-
somes and viable P. gingivalis.
Conclusions
In this study, we show that L. plantarum NC8 and
44048 are able to suppress P. gingivalis growth. Further-
more, bacteriocin PLNC8 αβ from L. plantarum NC8
are able to bind, at the nanomolar range, to P. gingivalis
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and cause cellular distortion through detachment of the
outer membrane and bacterial lysis. Soluble or immobi-
lized PLNC8 αβ bacteriocins may be used to prevent P.
gingivalis colonization and pathogenicity, and thus sup-
plement the host immune system against invading path-
ogens associated with periodontitis and other systemic
inflammatory diseases, including atherosclerosis.
Additional file
Additional file 1: Figure S1. Hydropathy scores of PLNC8 α and β. The
amino acid sequence of PLNC8 α (A) and PLNC8 β (B) and their
corresponding hydropathy score [46]. (TIF 369 kb)
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